Arkkila, Perttu

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: Interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

Younossi, Z. M., Ratziu, V., Loomba, R., Rinella, M., Anstee, Q. M., Goodman, Z., Bedossa, P., Geier, A., Beckebaum, S., Newsome, P. N., et al. (2019) · The Lancet

Liver Disease Diagnosis and TreatmentLiver Diseases and Immunity

Cited by 1,277

International consensus conference on stool banking for faecal microbiota transplantation in clinical practice

Cammarota, G., Ianiro, G., Kelly, C. R., Mullish, B. H., Allegretti, J. R., Kassam, Z., Putignani, L., Fischer, M., Keller, J. J., Costello, S. P., et al. (2019) · Gut

Clostridium difficile and Clostridium perfringens researchGut microbiota and health

Cited by 506

Gene expression in human NAFLD

Greco, D., Kotronen, A., Westerbacka, J., Puig, O., Arkkila, P., Kiviluoto, T., Laitinen, S., Kolak, M., Fisher, R. M., Hamsten, A., et al. (2008) · American Journal of Physiology-Gastrointestinal and Liver Physiology

Liver Disease Diagnosis and TreatmentDiet, Metabolism, and Disease

Cited by 427

Fecal transplantation, through colonoscopy, is effective therapy for recurrent Clostridium difficile infection

Mattila, E., Uusitalo–Seppälä, R., Wuorela, M., Lehtola, L., Nurmi, H., Ristikankare, M., Moilanen, V., Salminen, K., Seppälä, M., Mattila, P. S., et al. (2012) · Gastroenterology

Clostridium difficile and Clostridium perfringens researchGastrointestinal motility and disorders

Cited by 371

Fecal Microbiota Transplantation for Treatment of Parkinson Disease: A Randomized Clinical Trial

Scheperjans, F., Levo, R., Bosch, B., Lääperi, M., Pereira, P. A. B., Smolander, O.-P., Aho, V. T. E., Vetkas, N., Toivio, L., Kainulainen, V., et al. (2024) · JAMA Neurology

Parkinson's Disease Mechanisms and TreatmentsGut microbiota and health

Cited by 128

Risk of advanced fibrosis in first-degree relatives of patients with nonalcoholic fatty liver disease

Tamaki, N., Ahlholm, N., Luukkonen, P. K., Porthan, K., Sharpton, S. R., Ajmera, V., Kono, Y., Dave, S., Ahmed, A., Sundaram, V., et al. (2022) · Journal of Clinical Investigation

Liver Disease Diagnosis and TreatmentLiver Diseases and Immunity

Cited by 69

Effectiveness of Fecal Microbiota Transplantation for Weight Loss in Patients With Obesity Undergoing Bariatric Surgery: A Randomized Clinical Trial

Lahtinen, P., Juuti, A., Luostarinen, M., Niskanen, L., Liukkonen, T., Tillonen, J., Kössi, J., Ilvesmäki, V., Viljakka, M., Satokari, R., et al. (2022) · JAMA Network Open

Bariatric Surgery and OutcomesGut microbiota and health

Cited by 66

The burden of inflammatory bowel disease on health care utilization and quality of life

Nurmi, E., Haapamäki, J., Paavilainen, E., Rantanen, A., Hillilä, M., & Arkkila, P. (2013) · Scandinavian Journal of Gastroenterology

Inflammatory Bowel DiseaseHealth Systems, Economic Evaluations, Quality of Life

Cited by 66

Marked difference in liver fat measured by histology vs. magnetic resonance-proton density fat fraction: A meta-analysis

Qadri, S., Vartiainen, E., Lahelma, M., Porthan, K., Tang, A., Idilman, I. S., Runge, J. H., Juuti, A., Penttilä, A. K., Dabek, J., et al. (2024) · JHEP Reports

Liver Disease Diagnosis and TreatmentAdvanced MRI Techniques and Applications

Cited by 55